Quantgene is a deep genomics and AI company that detects disease-related patterns in the blood of patients using cell-free DNA. Quantgene has developed DeepGenā¢ - a deep genomics R&D platform used by liquid biopsy research teams to investigate somatic mutational patterns with unprecedented precision that can then be linked to cancer disease profiles. Quantgene DeepGen is the world's first turnkey deep genomics liquid biopsy platform to enable fast, reliable healthcare discovery at single-molecule precision.
To sponsor or exhibit contact:
André Singer
t/ 646.619.1797
andre.singer@terrapinn.com
To speak:
Anna Bagley
t/ 646 619-1803
anna.bagley@terrapinn.com